Organ transplantation is slowly emerging as an effective method for the treatment of end-stage organ failure. Due to the increasing incidence of chronic ailments, the demand for organ replacement has risen considerably around the world. This subsequently fuels demand for advanced immunosuppressant drugs to prevent organ rejection post transplantation.
Despite recent advances in medical science, post-operative complications are still a major challenge that the global organ replacement immunosuppressant drugs market needs to address. The long-standing inadequate medical coverage for immunosuppressant drugs can compromise the quality of care offered to patients suffering from organ failure. According to Transparency Market Research (TMR), this factor will translate into negative growth for the global organ transplant immunosuppressant drugs market from 2015 to 2023.
Get Report Sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1967
North America to Remain Leading Regional Market
On the basis of type of transplantation, the market is expected to witness the most promising demand from the kidney transplantation segment over the forecast period, which was also positioned the leading segment in terms of revenue contribution to the global market in 2014 with a 53.4% share. In terms of geography, the global organ transplant immunosuppressant drugs market earned much of its revenue from North America, a regional market that accounted for a massive 46.2% of the global market in 2014. The region is also expected to remain the leading regional market for organ transplant immunosuppressant drugs over the report’s forecast period.
Rising Prevalence of Life-threatening Diseases Heighten Scope of Organ Transplantation
One of the key factors driving the global market for organ transplant immunosuppressant drugs is the rising global prevalence of a number of life-threatening, chronic diseases, augmenting the demand for organ transplants. The number of people registering for organ replacements has massively increased in the past few years, leading to the increased scope of usage of organ transplant immunosuppressant drugs.
Expensive Organ Transplant Surgeries Limit their Global Adoption Rate
Organ transplant surgeries are highly expensive, limiting their scope of expansion, especially across a number of less-developed or emerging economies. Furthermore, the high cost incurred in post-transplantation patient care is also a significant barrier holding back the development of the global organ transplant immunosuppressant drugs market to a certain extent, especially across countries with middle-income populations. Factors such as inadequate health insurance coverage and undeveloped healthcare infrastructure also play a key role in debilitating the growth opportunities for the organ transplant immunosuppressant drugs market in a number of regional markets.